ETHOSOME ADVANTAGES

• Enhanced Permeation
  For transdermal and dermal delivery.
  
  
• Platform for the delivery of large and diverse group of drugs
  Including peptides and very lipophilic molecules.
  
  
• Various applications
  Pharmaceutical, Veterinary, Cosmetic.
  
  
• Covered by International Patents
  
  
• Efficient and Versatile
  Allowing transdermal delivery of various molecules with different chemical natures, hydrophilic and lipophilic molecules, peptides and other macromolecules. The delivery can be modulated for systemic or local delivery.
  
  
• Safe and approved components
  The carrier composition is safe and the components are approved for pharmaceutical and cosmetic use.
  
  
• Passive, non-invasive delivery system
  As opposed to a number of transdermal technologies under development, which are active and/or micro-invasive requiring further extensive research, the Ethosomal system is passive, noninvasive and is available for immediate commercialization.
  
  
• Low risk profile
  The technology has no large-scale drug development risk since the toxicological profiles of the Ethosomal components are well documented in the scientific literature.
  
  
• High patient compliance
  As opposed to micro-invasive and/or active transdermal technology, the Ethosomal drug is administrated in semisolid form (gel or cream), producing high patient compliance by is high. In contrast, Iontophoresis and Phonophoresis (other experimental transdermal technologies) are relatively complicated to use which will affect patient compliance.
  
  
• High cost to benefit ratio
  High market attractiveness for products with proprietary technology. Relatively simple to manufacture with no complicated technical investments.